Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Peringkat dalam Saham #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Harga Saham
$1.05
Kapitalisasi Pasar
$25.12M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-86.83%
Negara
US
Perdagangan Actuate Therapeutics Inc (ACTU)

Kategori

Riwayat pemecahan saham untuk Actuate Therapeutics Inc (ACTU)
Saham Actuate Therapeutics Inc (simbol: ACTU) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 19, 2026.
Satu lembar saham ACTU yang dibeli sebelum Aug 19, 2026 sekarang setara dengan 0 lembar saham ACTU.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH